MACS® Immuno-Oncology Days

MACS Dendritic Cells Day in Barcelona

Friday, July 5, 2019
9:00 a.m.–2:00 p.m.
Auditori CEK, C/Rosselló 149–153, Barcelona

Attendance is free of charge.
To register, please e-mail or call +34 91 512 12 90


09:00 a.m.Registration
09:30 a.m.Introduction
Daniel Benitez-Ribas
Dept. of Immunology, Hospital Clinic de Barcelona, IDIBAPS, Spain
09:45 a.m.Redefining bovine and porcine in vitro models of antigen presenting cells
Maria Montoya 
Centro de Investigaciones Biológicas, CIB-CSIC, Madrid, Spain
10:15 a.m.TH1 priming by vaccine dendritic cells depends on IL-12 production by endogenous migratory XCR1+ dendritic cells
Manfred Lutz
Institute for Virology and Immunobiology, Julius-Maximilian University of Würzburg, Germany
10:45 a.m.Autologous tolerogenic dendritic cells for rheumatoid arthritis: the AuToDeCRA study
Catharien Hilkens 
Institute of Cellular Medicine, Newcastle University, UK
11:15 a.m.Tumor-derived dendritic cells to slow down tumor growth
Damya Laoui 
Vrije Universiteit Brussel, VIB, Belgium
11:45 a.m.Coffee break
12:15 p.m.Human pDCs orchestrate the attraction of cytolytic immune effector cells in melanoma DC-vaccination
Georgina Flórez 
Dept. of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, Netherlands
12:45 p.m.Update on monocyte-derived dendritic cell vaccinations to treat leukemia and solid tumors
Evelien Smits 
Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital, Belgium
01:15 p.m.Personalized whole tumor antigen vaccines in ovarian cancer: using tumors for therapy
Lana Kandalaft
Center of Experimental Therapeutics, Ludwig Institute for Cancer Research, Lausanne, Switzerland
01:45 p.m.Discussion
02:00 p.m.Refreshments and networking